During the week of inauguration I was in Washington. A steady breeze blew on a warm winter day. Flags were flying. It was beautifully prepped and there was a lump in my throat. Even though I did not attend the ceremony in person, I felt the excitement of the inauguration. I whistled and walked with a spring in my step. I am proud to live in a country where power transitions are peaceful. As a political junkie, I anxiously watch the events unfold in the Trump administration. One of the top debates is healthcare. Here I offer a supply chain view.
The Affordable Care Act has had a massive effect on the US healthcare industry. Consumers want their healthcare insurers to stem increases in premiums, deductibles, and co-pays. And these demands, along with increased enrollment, additional regulatory compliance, and tighter operating budgets have all added to the pressure on healthcare supply chain executives to improve efficiencies.
Dynamox, a technology company in Florianopolis, Brazil, is marketing a new ultrahigh-frequency (UHF) RFID-enabled data logger that serves as a low-cost option for tracking goods in a cold supply chain using RFID sensors.
Healthcare is a unique value chain. Its demand arises not from want, but from need. Orders come not from the customer (patient) but from an intermediary (a doctor). And willingness to pay is often infinite. How can the supply chain principles that drive CPG and hi-tech work here?
A major California-based drug wholesaler has agreed to pay $150m to settle allegations that it failed to detect and report pharmacies' suspicious orders of prescription pain pills, federal prosecutors said last week.
Organizations who reported faster growth in revenue over the past three years were also more likely to be further ahead in using artificial intelligence, according to new research by IT consulting company Infosys.
In his press conference last week, Donald Trump launched an attack on the pharmaceutical industry. He called for their manufacturing facilities to return to U.S. production.